SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SEER

Seer, Inc. (NASDAQ:SEER)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$1.36-$0.03 (-1.81%)
 
Market cap
$75.9M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 4, 2020
Website
Market Cap$75.91M-31.0%
Revenue (ttm)$13.86M-13.3%
Net Income-$63.47M+20.0%
EPS-$1.15+14.2%
Shares Out55.81M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume130,275
Open$1.38
Previous Close$1.39
Day's Range$1.33 - $1.38
52-Week Range$1.33 - $2.38
Beta1.45
AnalystsHold
Price Target$4.00(+194.12%)
Earnings DateMar 4, 2027
-2.53% (1D)
No price history available.

About SEER

Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.

Address
3800 Bridge Parkway, Redwood City, CA, 94065, US
Market Cap
76 million
Employees
124
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$197.98K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From SEER’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.81%
5 Days
-12.26%
1 Month
-33.00%
6 Months
-23.16%
1 Year
-30.96%

$SEER stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SEER holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SEER's directors and management

Net Shares Purchased by Insiders−50k−25k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SEER Estimated quarterly lobbying spending

Source: U.S. Senate LDA

SEER Revenue by Segment

$1.77MTotal
Stock-based compensation$1.22M68.91%
Other$550.00K31.09%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New SEER patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SEER from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SEER

VTIVanguard Morningstar Total Stock Market ETF$1.62M
VXFVanguard Extended Market ETF$838.42K
IWCiShares Micro-Cap ETF$176.31K
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF$90.00K
AVSCAvantis U.S. Small Cap Equity ETF$85.22K
DFMCU.S. Micro Cap Portfolio ETF$52.39K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SEER’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Q3 2026 revenue growth with positive guidance update supports bullish tone, though coverage focuses on reporting facts rather than strong analyst enthusiasm.

Recent Insider Activity

Buys
0
Sells
8
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

TYNEDirexion Nanotechnology ETF0.82%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.09%

Weight is the stock’s share of each fund’s holdings.